BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9921992)

  • 1. Expression of somatostatin receptors in peritumoral veins of human tumors.
    Denzler B; Reubi JC
    Cancer; 1999 Jan; 85(1):188-98. PubMed ID: 9921992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction?
    Reubi JC; Horisberger U; Laissue J
    Int J Cancer; 1994 Mar; 56(5):681-8. PubMed ID: 8314345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging.
    Reubi JC
    J Nucl Med; 1995 Oct; 36(10):1846-53. PubMed ID: 7562054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels.
    Reubi JC; Schaer JC; Laissue JA; Waser B
    Metabolism; 1996 Aug; 45(8 Suppl 1):39-41. PubMed ID: 8769377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.
    Reubi JC; Waser B; Schaer JC; Laissue JA
    Eur J Nucl Med; 2001 Jul; 28(7):836-46. PubMed ID: 11504080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptors in human renal cell carcinomas.
    Reubi JC; Kvols L
    Cancer Res; 1992 Nov; 52(21):6074-8. PubMed ID: 1394233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
    Kvols LK; Reubi JC; Horisberger U; Moertel CG; Rubin J; Charboneau JW
    Yale J Biol Med; 1992; 65(5):505-18; discussion 531-6. PubMed ID: 1364090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
    Reubi JC; Schaer JC; Markwalder R; Waser B; Horisberger U; Laissue J
    Yale J Biol Med; 1997; 70(5-6):471-9. PubMed ID: 9825475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance-P receptors in human primary neoplasms: tumoral and vascular localization.
    Hennig IM; Laissue JA; Horisberger U; Reubi JC
    Int J Cancer; 1995 Jun; 61(6):786-92. PubMed ID: 7790112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.
    Reubi JC; Laissue J; Waser B; Horisberger U; Schaer JC
    Ann N Y Acad Sci; 1994 Sep; 733():122-37. PubMed ID: 7978860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
    Reubi JC; Schaer JC; Waser B; Mengod G
    Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
    Reubi JC; Schaer JC; Waser B
    Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
    Reubi JC; Waser B; Laissue JA; Gebbers JO
    Cancer Res; 1996 Apr; 56(8):1922-31. PubMed ID: 8620515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
    Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
    J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptors in human endocrine tumors.
    Reubi JC; Maurer R; von Werder K; Torhorst J; Klijn JG; Lamberts SW
    Cancer Res; 1987 Jan; 47(2):551-8. PubMed ID: 3024822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
    Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
    Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
    Behr TM; Béhé MP
    Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local up-regulation of neuropeptide receptors in host blood vessels around human colorectal cancers.
    Reubi JC; Mazzucchelli L; Hennig I; Laissue JA
    Gastroenterology; 1996 Jun; 110(6):1719-26. PubMed ID: 8964396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location.
    Reubi JC; Waser B; Liu Q; Laissue JA; Schonbrunn A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3882-91. PubMed ID: 11061553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors.
    Reubi JC; Waser B; Sheppard M; Macaulay V
    Int J Cancer; 1990 Feb; 45(2):269-74. PubMed ID: 1968052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.